Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy

BACKGROUND: Few studies have assessed the prevalence of mixed dyslipidemia (MD) and the effectiveness of lipid-modifying therapy (LMT) for the treatment of abnormal levels of low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) in Australia...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Colquhoun, David, Chirovsky, Diana, Sazonov, Valsilisa, Cui, Yadong A, Ambegaonkar, Baishali
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pulsus Group Inc 2013
Gaiak:
Clinical Cardiology: Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716499/
https://ncbi.nlm.nih.gov/pubmed/24294045
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak